The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1352
November 29, 2010
View Complete Issue         Table of Contents 2019 
Aliskiren/Amlodipine (Tekamlo): Another Combination Tablet for Hypertension
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Aliskiren/Amlodipine (Tekamlo): Another Combination Tablet for Hypertension
November 29, 2010 (Issue: 1352)
The FDA has approved Tekamlo (Novartis), an oral fixed-dose combination of the direct renin inhibitor aliskiren (Tekturna) and the calcium channel blocker amlodipine (Norvasc, and others), for treatment of hypertension in patients not adequately...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Aliskiren/Amlodipine (Tekamlo): Another Combination Tablet for Hypertension
Article code: 1352c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.